CTSS and chronic kidney disease: Over the past decade, there have been an increasing number of experimental and clinical molecular imaging studies using both CTSS and CTSB NIRF probes with their specific inhibitors for verification of the specificity of probes and individual proteases in atherosclerosis, cardiovascular inflammation, and chronic kidney disease [137, 138].